Citations

Showing 10 of 108104 citations.

A multicenter open-label phase II study of the efficacy and safety of palbociclib a cyclin-dependent kinases 4 and 6 inhibitor in patients with recurrent ovarian cancer.
Konecny, Gottfried E. , Hendrickson, Andrea E. Wahner , Jatoi, Aminah , Burton, Jill K., Paroly, Jill, Dowdy, Sean C. , Slamon, Dennis J. , Glaspy, John A.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 5557-5557

10.1200/jco.2016.34.15_suppl.5557 Get It

Refinement of prespecified cutoff for genomic loss of heterozygosity (LOH) in ARIEL2 part 1: A phase II study of rucaparib in patients (pts) with high grade ovarian carcinoma (HGOC).
Giordano, Heidi, Konecny, Gottfried E. , Tinker, Anna V. , Ma, Ling , Bell‐McGuinn, Katherine M., Cragun, Janiel M., Ray-Coquard, Isabelle Laure, Goble, Sandra, Maloney, Lara , McNeish, Iain A. , McNeish, Iain A , Coleman, Robert L. , Swisher, Elizabeth M. , Oza, Amit M. , Scott, Clare L. , Lin, Kevin , O’Malley, David M. , Kristeleit, Rebecca Sophie , Brenton, James D. , Oaknin, Ana , Kaufmann, Scott H.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 5540-5540

10.1200/jco.2016.34.15_suppl.5540 Get It

Prospective front-line management patterns in the Real World Metastatic Renal Cell Cancer (MaRCC) Registry.
Wolf, Steven , Costello, Brian A. , Vaishampayan, Ulka N. , Kyriakopoulos, Christos E. , Hammers, Hans J. , Tsao, Che‐Kai, Pal, Sumanta K. , Hussain, Arif , Borham, Azah, George, Daniel J. , Vaishampayan, Ulka , Harrison, Michael R. , Bhavsar, Nrupen Anjan , Stadler, Walter M. , Appleman, Leonard J. , Jim, Heather

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e16097-e16097

10.1200/jco.2016.34.15_suppl.e16097 Get It

Deferred systemic therapy (DST) in the prospective metastatic renal cell cancer (MaRCC) registry.
Wolf, Steven , Costello, Brian A. , Vaishampayan, Ulka N. , Kyriakopoulos, Christos E. , Hammers, Hans J. , Tsao, Che‐Kai, Pal, Sumanta K. , Hussain, Arif , Borham, Azah, George, Daniel J. , Vaishampayan, Ulka , Harrison, Michael R. , Bhavsar, Nrupen Anjan , Stadler, Walter M. , Appleman, Leonard J. , Jim, Heather

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e16084-e16084

10.1200/jco.2016.34.15_suppl.e16084 Get It

Effect of intravenous contrast on renal function in advanced and metastatic renal cell carcinoma.
Patel, Sagar Shashi, Cherington, Chad, Tyson, Mark D. , Castle, Erik P., Ho, Thai H.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e16071-e16071

10.1200/jco.2016.34.15_suppl.e16071 Get It

Validation of a genomic risk classifier to predict prostate cancer-specific mortality (PCSM) in high-risk patients.
Karnes, Jeffrey , Ross, Ashley E. , Erho, Nicholas , Yousefi, Kasra, Takhar, Mandeep, Schaeffer, Edward M. , Klein, Eric A. , Davicioni, Elai , Trock, Bruce J

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 5056-5056

10.1200/jco.2016.34.15_suppl.5056 Get It

Deciphering the genomic fingerprint of small cell prostate cancer with potential clinical utility in radical prostatectomy tissues.
Alshalalfa, Mohammed , Haddad, Zaid , Ross, Ashley E. , Karnes, Jeffrey , Tsai, Harrison , Davicioni, Elai , Schaeffer, Edward M. , Lotan, Tamara Levin

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 5055-5055

10.1200/jco.2016.34.15_suppl.5055 Get It

HSD3B1 and resistance to androgen deprivation therapy in prostate cancer.
AbuAli, Ghada, Reichard, Chad A. , Chang, Kai‐Hsiung , Carlson, Rachel E. , Rangel, Laureano J. , Reagan, Kevin, Davis, Brian A., Karnes, Jeffrey , Tindall, Donald J., Sharifi, Nima , Hearn, Jason W.D. , Reddy, Chandana A. , Magi‐Galluzzi, Cristina , Davis, Brian, Kohli, Manish , Klein, Eric A.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 5015-5015

10.1200/jco.2016.34.15_suppl.5015 Get It

Pharmacological targeting of the Aurora A and histone 3 lysine 9 methyltransferase pathways in pancreatic cancer.
Salmonson, Ann, Missfeldt, Mckenna, Assuncao, Thiago de, Bintz, Jennifer , Lomberk, Gwen , Lomberk, Gwen L , Mathison, Angela , Iovanna, Juan , Huebert, Robert C.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e15715-e15715

10.1200/jco.2016.34.15_suppl.e15715 Get It

Survival of patients with oligometastatic pancreatic ductal adenomacarcinoma treated with combined modality treatment including surgical resection: A pilot study.
Kandel, Pujan , Mody, Kabir , Asbun, Horacio J. , Bolan, Candice W. , Bridges, Mellena D., Woodward, Timothy A., Gómez, Victoria , Wallace, Michael B. , Wallace, Michael B , Stauffer, John , Raimondo, Massimo

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e15690-e15690

10.1200/jco.2016.34.15_suppl.e15690 Get It